–
Atea Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
138
FY22:
−131
FY23:
−164
FY24:
−193
FY25:
−181
(positive)
Change from FY21 to FY25
millions USD
FY21:
138
FY22:
−130
FY23:
−164
FY24:
−193
FY25:
−180
(positive)
Change from FY21 to FY25
millions USD
FY21:
139
FY22:
−119
FY23:
−135
FY24:
−167
FY25:
−165
(positive)
Change from FY21 to FY25
millions USD
FY21:
121
FY22:
−116
FY23:
−136
FY24:
−168
FY25:
−158
All amounts in millions USD